Publications by authors named "Mark Hertzberg"

73Publications

DA-EPOCH-R in Burkitt Lymphoma: Is It Enough for High-Risk Disease?

J Clin Oncol 2020 Sep 15:JCO2001850. Epub 2020 Sep 15.

Mark Hertzberg, MBBS, PhD, Department of Haematology, Prince of Wales Hospital and University of New South Wales, Sydney, NSW, Australia; David J.L. Joske, MBBS, Department of Haematology, Sir Charles Gairdner Hospital, and University of Western Australia, Perth, WA, Australia; and Maher K. Gandhi, MBChB, PhD, Mater Research Institute, University of Queensland, and Princess Alexandra Hospital, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.20.01850DOI Listing
September 2020

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

Blood Adv 2020 Jul;4(13):3180-3190

Center for International Blood and Marrow Transplant Research, Department of Medicine, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019001266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362362PMC
July 2020

Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety.

J Clin Oncol 2018 08 1;36(23):2395-2404. Epub 2018 Jun 1.

Wolfgang Hiddemann and Roswitha Forstpointner, University Hospital, Ludwig Maximilian University Munich, Munich; Jan Dürig, University Hospital Essen, Essen; Michael Herold, HELIOS-Klinikum Erfurt, Erfurt, Germany; Anna Maria Barbui, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy; Miguel A. Canales, Hospital Universitario la Paz, Madrid, Spain; Paul K. Cannell, Fiona Stanley Hospital, Murdoch, Western Australia; Mark Hertzberg, Prince of Wales Hospital; Judith Trotman, Concord Repatriation General Hospital, University of Sydney, Sydney, New South Wales; John F. Seymour, Royal Melbourne Hospital, and University of Melbourne, Melbourne, Victoria, Australia; Graham P. Collins, Churchill Hospital, Oxford; John Radford, University of Manchester and the Christie National Health Service Foundation Trust, Manchester Academic Health Science Centre, Manchester; Robert E. Marcus, Kings College Hospital, London, United Kingdom; Magdalena Klanova, Charles University General Hospital, Prague, Czech Republic; Magdalena Klanova, Alis Burciu, Günter Fingerle-Rowson, Marcel Wolbers, and Tina Nielsen, F. Hoffmann-La Roche, Basel, Switzerland; and Kensei Tobinai, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.8960DOI Listing
August 2018

High-risk DLBCL: interim PET? Not yet.

Authors:
Mark Hertzberg

Blood 2017 09;130(11):1277-1278

PRINCE OF WALES HOSPITAL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-07-797381DOI Listing
September 2017

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

J Clin Oncol 2017 May 3;35(15):1678-1685. Epub 2017 Apr 3.

Kenneth F. Bradstock and Warwick Benson, Westmead Hospital, University of Sydney; Arno Enno, Sandra Deveridge, and Philip Rowlings, Calvary Mater Newcastle Hospital, Newcastle; Luke Coyle, Royal North Shore Hospital, St Leonards; Campbell Tiley, Central Coast Health, Gosford; John Moore, St Vincent's Hospital; Mark Hertzberg, Prince of Wales Hospital, Sydney; Kimberly Cartwright, Wollongong Hospital, Wollongong; Ilona Cunningham, Concord Repatriation General Hospital, Concord; John Taper, Nepean Hospital, Penrith, New South Wales; Emma Link, Juliana Di Iulio, and John F. Seymour, Peter MacCallum Cancer Centre; Jeff Szer, Andrew Grigg, Andrew W. Roberts, and John F. Seymour, University of Melbourne; Andrew H. Wei, Monash University; Anthony Schwarer, Box Hill Hospital; Lynda Campbell, Victorian Cancer Cytogenetics Service, Melbourne; Jeff Szer, Andrew Grigg, and Andrew W. Roberts, Royal Melbourne Hospital, Parkville; Phillip Campbell, Deakin University School of Medicine, Geelong, Victoria; Paula Marlton, Anthony K. Mills, and Devinder Gill, University of Queensland, Brisbane, Queensland; Ray M. Lowenthal, University of Tasmania, Hobart, Tasmania; Ian D. Lewis and Peter Bardy, Royal Adelaide Hospital; Uwe Hahn, Queen Elizabeth Hospital, Adelaide, South Australia; James D'Rozario, The Canberra Hospital, Garran, Canberra, Australia Capital Territory; Gavin Cull, Sir Charles Gairdner Hospital; Michael F. Leahy, University of Western Australia; and Paul Cannell, Royal Perth Hospital, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.70.6374
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.70.6374DOI Listing
May 2017

Quantum Gravitational Force Between Polarizable Objects.

Phys Rev Lett 2016 04 15;116(15):151301. Epub 2016 Apr 15.

Institute of Cosmology, Department of Physics and Astronomy, Tufts University, Medford, Massachusetts 02155, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1103/PhysRevLett.116.151301DOI Listing
April 2016

What They Want: Inclusion of Blood and Marrow Transplantation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia.

Biol Blood Marrow Transplant 2016 04 30;22(4):731-743. Epub 2015 Dec 30.

Northern Clinical School, Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia; Northern Blood Research Centre, Kolling Institute, University of Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.12.019DOI Listing
April 2016

Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.

Lancet Haematol 2015 Oct 1;2(10):e445-55. Epub 2015 Oct 1.

University of Queensland Diamantina Institute, Translational Research Institute, University of Queensland, Brisbane, QLD, Australia; Princess Alexandra Hospital, Brisbane, QLD, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(15)00150-7DOI Listing
October 2015

TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets.

Blood 2015 Feb 17;125(6):915-23. Epub 2014 Dec 17.

Department of Haematology, and Discipline of Medicine, School of Medicine, University of Adelaide, Adelaide, Australia; Australasian Leukemia and Lymphoma Group, Melbourne, Australia; Cancer Theme, South Australia Health and Medical Research Institute, Adelaide, Australia;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-07-590315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161008PMC
February 2015

Gemcitabine and vinorelbine treatment in cutaneous T-cell lymphoma in four patients.

Australas J Dermatol 2015 Nov 13;56(4):294-7. Epub 2014 Dec 13.

Department of Dermatology, Westmead Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajd.12270DOI Listing
November 2015

Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: five cases, a literature review and discussion of management.

Br J Haematol 2015 Feb 25;168(3):350-60. Epub 2014 Sep 25.

Department of Haematology, Royal North Shore Hospital, St Leonards, Sydney, NSW, Australia; Kolling Institute, University of Sydney, St Leonards, Sydney, NSW, Australia; Chronic Lymphocytic Leukaemia Australian Research Consortium (CLLARC), Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13134DOI Listing
February 2015

Relapsed/refractory Hodgkin lymphoma: what is the best salvage therapy and do we need RIC-alloSCT?

Authors:
Mark Hertzberg

Hematol Oncol Clin North Am 2014 Feb;28(1):123-47

Department of Haematology, Level 2 ICPMR, Westmead Hospital, Darcy Road, Westmead, New South Wales 2145, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2013.09.001DOI Listing
February 2014

Oscillons after inflation.

Phys Rev Lett 2012 Jun 14;108(24):241302. Epub 2012 Jun 14.

Department of Physics, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1103/PhysRevLett.108.241302DOI Listing
June 2012

Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAP.

Pathology 2012 Apr;44(3):240-7

Royal College of Pathologists of Australasia (RCPA) Haematology Quality Assurance Program (QAP), Northmead, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0b013e32834d7b83DOI Listing
April 2012

Some calculable contributions to entanglement entropy.

Phys Rev Lett 2011 Feb 4;106(5):050404. Epub 2011 Feb 4.

Center for Theoretical Physics, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1103/PhysRevLett.106.050404DOI Listing
February 2011

The Clinical Impact of Infection with Swine Flu (H1N109) Strain of Influenza Virus in Hematopoietic Stem Cell Transplant Recipients.

Biol Blood Marrow Transplant 2011 Jan 15;17(1):147-53. Epub 2010 Jul 15.

Department of Haematology, Level II ICPMR, Westmead Hospital, Westmead, NSW 2145, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.07.004DOI Listing
January 2011

Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma.

Clin Cancer Res 2009 Jan;15(2):714-22

Clinical Haematology/Bone Marrow Transplant Department, The Alfred Hospital, Commercial Road, Prahran, Melbourne, Victoria, Australia 3181.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1022DOI Listing
January 2009

Melting of persistent double-stranded polymers.

Phys Rev E Stat Nonlin Soft Matter Phys 2008 Nov 12;78(5 Pt 1):051910. Epub 2008 Nov 12.

Department of Physics, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1103/PhysRevE.78.051910DOI Listing
November 2008

Optimizing fusion transcript monitoring in CML.

Blood 2007 Mar;109(5):2263; author reply 2263-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-08-043588DOI Listing
March 2007

Laboratory diagnosis of von Willebrand disorder: use of multiple functional assays reduces diagnostic error rates.

Lab Hematol 2005 ;11(2):91-7

Department of Haematology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://cardenjennings.metapress.com/openurl.asp?genre=articl
Publisher Site
http://dx.doi.org/10.1532/LH96.04063DOI Listing
October 2005

External quality assurance of DNA testing for thrombophilia mutations.

Am J Clin Pathol 2005 Feb;123(2):189-93

Department of Haematology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Australia.

View Article

Download full-text PDF

Source
February 2005

Genetic testing for thrombophilia mutations.

Authors:
Mark S Hertzberg

Semin Thromb Hemost 2005 Feb;31(1):33-8

Department of Haematology, Westmead Hospital, Westmead, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2005-863803DOI Listing
February 2005

Nephrotic syndrome after stem cell transplantation.

Clin Transplant 2005 Feb;19(1):141-4

Department of Haematology, University of Sydney, Westmead Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1399-0012.2004.00294.xDOI Listing
February 2005

Laboratory diagnosis of von Willebrand disorder. Current practice in the southern hemisphere.

Am J Clin Pathol 2003 Jun;119(6):882-93

Department of Haematology, RCPA Quality Assurance Program, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/8WVA-NM7H-0DKT-GB9FDOI Listing
June 2003

Cytomegalovirus-specific CD4+ and CD8+ T-cells follow a similar reconstitution pattern after allogeneic stem cell transplantation.

Biol Blood Marrow Transplant 2002 ;8(9):501-11

Westmead Institute for Cancer Research, Westmead Millennium Institute, University of Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/bbmt.2002.v8.pm12374455DOI Listing
June 2003

Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods.

Am J Clin Pathol 2002 Aug;118(2):269-76

Haemostasis Laboratory, Haematology Division, Institute of Medical and Veterinary Science, University of South Australia, Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/2D6F-RR03-8EFN-28F5DOI Listing
August 2002

Stage IV CD30+ anaplastic large cell lymphoma: response to acitretin and interferon-alpha.

Australas J Dermatol 2002 Aug;43(3):207-10

Department of Dermatology, Westmead Hospital, Westmead, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1440-0960.2002.00597.xDOI Listing
August 2002